LBTD (Lotus Bio-Technology Development) Scaled Net Operating Assets: N/A (As of Dec. 2017)


What is Lotus Bio-Technology Development Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lotus Bio-Technology Development's operating assets for the quarter that ended in Dec. 2017 was $0.00 Mil. Lotus Bio-Technology Development's operating liabilities for the quarter that ended in Dec. 2017 was $0.12 Mil. Lotus Bio-Technology Development's Total Assets for the quarter that ended in Sep. 2017 was $0.00 Mil. Therefore, Lotus Bio-Technology Development's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2017 was N/A.


Lotus Bio-Technology Development Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Scaled Net Operating Assets Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.00 -6.50 0.00 -31.00 -15.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.80 -18.75 0.00 0.00 0.00

LBTD vs SNES, CVAT: Scaled Net Operating Assets Comparison

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Bio-Technology Development Scaled Net Operating Assets vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's Scaled Net Operating Assets falls into.



Lotus Bio-Technology Development Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lotus Bio-Technology Development's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2017 )
=(Operating Assets (A: Mar. 2017 )-Operating Liabilities (A: Mar. 2017 ))/Total Assets (A: Mar. 2016 )
=(0-0.075)/0.005
=-15.00

where

Operating Assets(A: Mar. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0 - 0
=0

Operating Liabilities(A: Mar. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.081 - 0 - 0.006
=0.075

Lotus Bio-Technology Development's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2017 )
=(Operating Assets (Q: Dec. 2017 )-Operating Liabilities (Q: Dec. 2017 ))/Total Assets (Q: Sep. 2017 )
=(0.005-0.117)/0
=N/A

where

Operating Assets(Q: Dec. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.055 - 0.05
=0.005

Operating Liabilities(Q: Dec. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.117 - 0 - 0
=0.117

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.